October 26, 2017 by Chain Drug Review
Chris Carr, CVS drug disposal kiosks, CVS Health, CVS medication disposal program, CVS Pharmacy, Drug Enforcement Administration, Josh Shapiro, Josh Stein, National Prescription Drug Take-Back Day, Thomas Moriarty
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health has officially expanded its safe medication disposal kiosk program to CVS Pharmacy stores. The company said new CVS drug disposal kiosks are now inside 750 CVS Pharmacy locations, adding to the 800-plus units that the company has donated to law enforcement nationwide, which have collected more than 100 metric tons
April 26, 2017 by Geoff Walden
Drug Enforcement Administration, naloxone, National Prescription Drug Take-Back Day, prescription drug abuse, Richard Ashworth, Walgreens, Walgreens medication disposal kiosks
Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill. — Walgreens has collected and safely disposed of 72 tons of medication since launching its drug disposal program 14 months ago. Walgreens said Wednesday that its safe medication disposal program is the first ongoing national effort of its kind by a retailer to combat the national drug abuse crisis and help fight the
April 26, 2017 by Brian Bossetta
Betsy Walker, Cardinal Health, Cardinal Health Foundation, Drug Enforcement Administration, Generation Rx, Medication Disposal Grant Program, National Prescription Drug Take-Back Day, Ohio State University College of Pharmacy, prescription drug abuse, Steve Lawrence
Pharmacy, Supplier News
DUBLIN, Ohio — As part of its effort to fight prescription drug abuse, the Cardinal Health Foundation is urging the public to participate in National Prescription Drug Take-Back Day on Saturday. The event, held April 29 from 10 a.m. to 2 p.m. and hosted by the Drug Enforcement Administration (DEA), aims to help prevent medication abuse
January 20, 2017 by Chain Drug Review
controlled substances, Controlled Substances Act, Costco pharmacies, Costco Wholesale Corp., Department of Justice, Drug Enforcement Administration
Leading Headlines, Pharmacy, Retail News
WASHINGTON — Costco Wholesale Corp. has agreed to pay $11.75 million in a settlement with the Department of Justice (DOJ) on claims that it improperly filled prescriptions for controlled substances. Also under the settlement, over the next three years the Drug Enforcement Administration (DEA) can conduct unannounced and unrestricted inspections of all DEA-registered Costco pharmacy
January 18, 2017 by Chain Drug Review
AmerisourceBergen, Cardinal Health, Controlled Substances Act, DEA, Department of Justice, distribution of opioid medications, DOJ, Drug Enforcement Administration, John Hammergren, McKesson, prescription drug abuse, prescription drug diversion
Leading Headlines, Pharmacy, Supplier News
SAN FRANCISCO — McKesson Corp. has agreed to pay $150 million in a settlement with the Drug Enforcement Administration (DEA) and Department of Justice (DOJ) involving its monitoring and reporting of suspicious controlled substance orders. McKesson said late Tuesday that under the administrative and civil settlements the DEA will suspend the company’s DEA registrations to
December 28, 2016 by Chain Drug Review
Cardinal Health, Craig Morford, Department of Justice, Drug Enforcement Administration, prescription drug abuse
Leading Headlines, Pharmacy, Supplier News
DUBLIN, Ohio — Cardinal Health Inc. has reached a nationwide settlement with the federal government that resolves the outstanding civil penalty portion of its 2012 administrative settlement with the Drug Enforcement Administration (DEA). Cardinal Health said it has agreed to pay $44 million to the Department of Justice (DOJ) under the settlement. The DOJ —
December 5, 2016 by Catherine O'Neil, Shannon Cox and Chain Drug Review
Catherine O'Neil, Controlled Substances Act, Drug Enforcement Administration, King & Spalding, pharmacy compliance review, pharmacy regulations, pharmacy regulatory issues, Shannon Cox, state pharmacy board inspections
Opinion
A regulatory inspection by the Drug Enforcement Administration or a state board of pharmacy can be a high stakes event. Penalties for violations of the federal Controlled Substances Act may include criminal penalties, significant civil monetary fines and administrative action up to and including a “show cause” proceeding to suspend or revoke a pharmacy’s controlled
April 22, 2016 by Chain Drug Review
Alex Gourlay, drug abuse, Drug Enforcement Administration, expired medications, Kevin McCarthy, naloxone, National Prescription Drug Take-Back Day, Roberto Valencia, safe medication disposal kiosks, Shannon Grove, Walgreens
Pharmacy, Retail News
DEERFIELD, Ill. — Walgreens has deployed 50 safe medication disposal kiosks in drug stores across California. The drug chain said Friday that the kiosks provide Californians with a safe, convenient way to discard unwanted, unused or expired medications — including prescripton drugs, controlled substances and over-the-counter medicines — at no cost. To kick off the
May 15, 2012 by Chain Drug Review
Cardinal Health, Drug Enforcement Administration, George Barrett, oxycodone, prescription drug abuse
Retail News
DUBLIN, Ohio — In a settlement with the Drug Enforcement Agency (DEA), Cardinal Health Inc. has agreed to a two-year suspension of its Lakeland, Fla., distribution center’s registration to ship controlled substances. The pharmaceutical distributor said Tuesday that under the settlement it also has agreed to improve certain anti-diversion procedures. Cardinal noted that the agreement